Alzheimer disease.
Castellani
Rudy J
RJ
Rolston
Raj K
RK
Smith
Mark A
MA
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000814:Aniline Compounds; D000975:Antioxidants / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000473:pathology; D016657:Cerebral Amyloid Angiopathy / Q000175:diagnosis; D018678:Cholinergic Agents / Q000627:therapeutic use; D003704:Dementia / Q000175:diagnosis; D003937:Diagnosis, Differential; D038441:Diet, Mediterranean; D015914:Estrogen Replacement Therapy; D014943:Global Health; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D015994:Incidence; D009154:Mutation / Q000235:genetics; D009414:Nerve Growth Factors / Q000627:therapeutic use; D016874:Neurofibrillary Tangles; D058225:Plaque, Amyloid; D049268:Positron-Emission Tomography; D015995:Prevalence; D012307:Risk Factors; D013844:Thiazoles; D016896:Treatment Outcome; D016875:tau Proteins / Q000378:metabolism
C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D016229:Amyloid beta-Peptides; D000814:Aniline Compounds; D000975:Antioxidants; D015415:Biomarkers; D018678:Cholinergic Agents; D009414:Nerve Growth Factors; D013844:Thiazoles; D016875:tau Proteins